1. Home
  2. ACRV vs VTSI Comparison

ACRV vs VTSI Comparison

Compare ACRV & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.39

Market Cap

53.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRV
VTSI
Founded
2018
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
53.2M
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
ACRV
VTSI
Price
$1.65
$4.39
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$13.00
$7.00
AVG Volume (30 Days)
864.7K
27.9K
Earning Date
03-19-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
15.13
N/A
EPS
N/A
0.09
Revenue
N/A
$16,524,225.00
Revenue This Year
N/A
N/A
Revenue Next Year
$691.78
$13.39
P/E Ratio
N/A
$48.44
Revenue Growth
N/A
5.57
52 Week Low
$1.05
$3.57
52 Week High
$5.65
$7.47

Technical Indicators

Market Signals
Indicator
ACRV
VTSI
Relative Strength Index (RSI) 49.01 51.13
Support Level $1.49 $4.21
Resistance Level $1.86 $4.49
Average True Range (ATR) 0.11 0.17
MACD 0.02 0.03
Stochastic Oscillator 66.18 64.00

Price Performance

Historical Comparison
ACRV
VTSI

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: